Complications in major depressive disorder therapy: A review of magnetic resonance spectroscopy studies

Functional Neurology

Volumn 23, Issue 3, 2008, Pages 129-132

  Caverzasi, Eduardo ^a   Pichiecchio, Anna ^a   Calligaro, Alessandro ^b   Pasin, Moreno ^a   Giugni, Elisabetta ^c   Pasquini, Massimo ^b   Biondi, Massimo ^b   Barale, Francesco ^d   Bastianello, Stefano ^a,d  

^a C MONDINO NATIONAL NEUROLOGICAL INSTITUTE   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c IRCCS SAN RAFFAELE PISANA   (Italy)

^d UNIVERSITY OF PAVIA   (Italy)

Author keywords

Advanced MRI technique; Major depression disorder; Spectroscopy; Therapy

Indexed keywords

SEROTONIN UPTAKE INHIBITOR;

BRAIN ATROPHY; ELECTROCONVULSIVE THERAPY; HIPPOCAMPUS; HUMAN; MAJOR DEPRESSION; MEDICAL RESEARCH; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PROTON NUCLEAR MAGNETIC RESONANCE; REVIEW;

ASPARTIC ACID; BRAIN CHEMISTRY; CHOLINE; CREATINE; DEPRESSIVE DISORDER, MAJOR; ELECTROCONVULSIVE THERAPY; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; PUBMED; SEROTONIN UPTAKE INHIBITORS;

EID: 58649119339     PISSN: 03935264     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (14)

1. Lucignani G, Bastianello S. Neuroimaging: a story of physicians and basic scientists. Funct Neurol 2006;21: 133-136
2. Cavanna AE, Strigaro G, Monaco F. Brain mechanisms underlying the placebo effect in neurological disorders. Funct Neurol 2007;22:89-94
3. Ende G, Demirakca T, Tost H. The biochemistry of dysfunctional emotions: proton MR spectroscopic findings in major depressive disorder. Prog Brain Res 2006;156:481-501
4. Michelson D, Fava M, Amsterdam J, Apter J, Londborg P, Tamura R, Tepner RG. Interruption of selective serotonin reuptake inhibitor treatment. Double-blind, placebo-controlled trial. Br J Psychiatry 2000;176:363-368
5. Sackeim HA, Freeman J, McElhiney M, Coleman E, Pru-dic J, Devanand DP. Effects of major depression on estimates of intelligence. J Clin Exp Neuropsychol 1992;14: 268-288
6. Vythilingam M, Vermetten E, Anderson GM, Luckenbaugh D, Anderson ER, Snow J, Staib LH, Charney DS, Bremn-er JD. Hippocampal volume, memory, and cortisol status in major depressive disorder: effects of treatment. Biol Psychiatry 2004;56:101-112
7. Ende G, Braus DF, Walter S, Weber-Fahr W, Henn FA. The hippocampus in patients treated with electroconvul-sive therapy: a proton magnetic resonance spectroscopic imaging study. Arch Gen Psychiatry 2000;57:937-943
8. Obergriesser T, Ende G, Braus DF, Henn FA. Long-term follow-up of magnetic resonance-detectable choline signal changes in the hippocampus of patients treated with elec-troconvulsive therapy. J Clin Psychiatry 2003;64: 775-780
9. Kaufman MJ, Henry ME, Frederick B, Hennen J, Villa-fuerte RA, Stoddard EP, Schmidt ME, Cohen BM, Ren-shaw PF. Selective serotonin reuptake inhibitor discontinuation syndrome is associated with a rostral anterior cin-gulate choline metabolite decrease: a proton magnetic resonance spectroscopic imaging study. Biol Psychiatry 2003;54:534-539
10. Duman RS, Vaidya VA. Molecular and cellular actions of chronic electroconvulsive seizures. J ECT 1998;14:181-193
11. Vaidya VA, Siuciak JA, Du F, Duman RS. Hippocampal mossy fiber sprouting induced by chronic electroconvul-sive seizures. Neuroscience 1999;89:157-166
12. Gombos Z, Spiller A, Cottrell GA, Racine RJ, McIntyre Burnham W. Mossy fiber sprouting induced by repeated electroconvulsive shock seizures. Brain Res 1999;844:28-33
13. Sonawalla SB, Renshaw PF, Moore CM, Alpert JE, Nieren-berg AA, Rosenbaum JF, Fava M. Compounds containing cytosolic choline in the basal ganglia: a potential biological marker of true drug response to fluoxetine. Am J Psychiatry 1999;156:1638-1640
14. Auer DP, Pütz B, Kraft E, Lipinski B, Schill J, Holsboer F. Reduced glutamate in the anterior cingulate cortex in depression: an in vivo proton magnetic resonance spec-troscopy study. Biol Psychiatry 2000;47:305-301